Nothing Special   »   [go: up one dir, main page]

CY1106973T1 - Παραγωγα θειαζολινης ως εκλεκτικοι διαμορφωται υποδοχεως ανδρογονου (sarms) - Google Patents

Παραγωγα θειαζολινης ως εκλεκτικοι διαμορφωται υποδοχεως ανδρογονου (sarms)

Info

Publication number
CY1106973T1
CY1106973T1 CY20071101413T CY071101413T CY1106973T1 CY 1106973 T1 CY1106973 T1 CY 1106973T1 CY 20071101413 T CY20071101413 T CY 20071101413T CY 071101413 T CY071101413 T CY 071101413T CY 1106973 T1 CY1106973 T1 CY 1106973T1
Authority
CY
Cyprus
Prior art keywords
androgen
thaizolin
sarms
conductors
products
Prior art date
Application number
CY20071101413T
Other languages
English (en)
Inventor
Raymond A Ng
Zhihua Sui
Original Assignee
Janssen Pharmaceutica N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica N.V. filed Critical Janssen Pharmaceutica N.V.
Publication of CY1106973T1 publication Critical patent/CY1106973T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Virology (AREA)
  • Dermatology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Oncology (AREA)
  • Gynecology & Obstetrics (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Urology & Nephrology (AREA)
  • Communicable Diseases (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Η παρούσα εφεύρεσις αναφέρεται εις νέα παράγωγα θειαζολίνης του γενικού τύπου (Ι)˙ εις τον οποίον όλες οι μεταβλητές είναι ως καθορίζονται ενταύθα, φαρμακευτικαί συνθέσεις περιέχουσαι αυτά και χρήσις των εις την θεραπείαν διαταραχών και καταστάσεων διαμορφωμένων υπό του υποδοχέως ανδρογόνου.
CY20071101413T 2003-06-13 2007-11-05 Παραγωγα θειαζολινης ως εκλεκτικοι διαμορφωται υποδοχεως ανδρογονου (sarms) CY1106973T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US47871203P 2003-06-13 2003-06-13
EP04755044A EP1656360B1 (en) 2003-06-13 2004-06-12 Thiazoline derivatives as selective androgen receptor modulators (sarms)

Publications (1)

Publication Number Publication Date
CY1106973T1 true CY1106973T1 (el) 2012-09-26

Family

ID=33539114

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20071101413T CY1106973T1 (el) 2003-06-13 2007-11-05 Παραγωγα θειαζολινης ως εκλεκτικοι διαμορφωται υποδοχεως ανδρογονου (sarms)

Country Status (14)

Country Link
US (1) US20050014952A1 (el)
EP (1) EP1656360B1 (el)
JP (1) JP4898446B2 (el)
CN (1) CN1835937B (el)
AT (1) ATE370133T1 (el)
AU (1) AU2004249697B2 (el)
CA (1) CA2528764A1 (el)
CY (1) CY1106973T1 (el)
DE (1) DE602004008300T2 (el)
DK (1) DK1656360T3 (el)
ES (1) ES2291906T3 (el)
PL (1) PL1656360T3 (el)
PT (1) PT1656360E (el)
WO (1) WO2004113309A1 (el)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006055184A2 (en) 2004-11-16 2006-05-26 Janssen Pharmaceutica N.V. Novel heterocycle derivatives useful as selective androgen receptor modulators (sarms)
US7709516B2 (en) 2005-06-17 2010-05-04 Endorecherche, Inc. Helix 12 directed non-steroidal antiandrogens
US9284345B2 (en) 2007-04-12 2016-03-15 Endorecherche, Inc. 17alpha-substituted steroids as systemic antiandrogens and selective androgen receptor modulators
JP2015508414A (ja) * 2012-01-12 2015-03-19 イエール ユニバーシティ Ｅ３ユビキチンリガーゼによる標的タンパク質および他のポリペプチドの分解増強のための化合物および方法
CN103450112B (zh) * 2013-08-07 2019-09-13 华东理工大学 一种n-桥连接的含氮五元杂环化合物及其制备与用途
US9682960B2 (en) 2013-12-19 2017-06-20 Endorecherche, Inc. Non-steroidal antiandrogens and selective androgen receptor modulators with a pyridyl moiety
CA3138197A1 (en) 2019-05-14 2020-11-19 Nuvation Bio Inc. Anti-cancer nuclear hormone receptor-targeting compounds
WO2021097046A1 (en) 2019-11-13 2021-05-20 Nuvation Bio Inc. Anti-cancer nuclear hormone receptor-targeting compounds
MX2023011241A (es) 2021-03-23 2023-10-03 Nuvation Bio Inc Compuestos dirigidos a receptores de hormonas nucleares contra el cancer.
US12006314B2 (en) 2021-05-03 2024-06-11 Nuvation Bio Inc. Anti-cancer nuclear hormone receptor-targeting compounds

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0741714A1 (en) * 1994-01-24 1996-11-13 E.I. Du Pont De Nemours And Company Arthropodicidal 2-oxa and thia-zolines
US6403623B1 (en) * 1999-05-27 2002-06-11 Unuversity Of Notre Dame Du Lac Heterocyclic antituberculosis agents
AU8523001A (en) * 2000-08-24 2002-03-04 Gtx Inc Selective androgen receptor modulators and methods of use thereof

Also Published As

Publication number Publication date
EP1656360A1 (en) 2006-05-17
CA2528764A1 (en) 2004-12-29
PL1656360T3 (pl) 2008-01-31
AU2004249697A1 (en) 2004-12-29
EP1656360B1 (en) 2007-08-15
US20050014952A1 (en) 2005-01-20
WO2004113309A1 (en) 2004-12-29
AU2004249697B2 (en) 2010-04-22
DE602004008300T2 (de) 2008-05-08
PT1656360E (pt) 2007-10-22
DK1656360T3 (da) 2007-12-27
JP4898446B2 (ja) 2012-03-14
CN1835937A (zh) 2006-09-20
ATE370133T1 (de) 2007-09-15
DE602004008300D1 (de) 2007-09-27
CN1835937B (zh) 2012-07-18
JP2007501287A (ja) 2007-01-25
ES2291906T3 (es) 2008-03-01

Similar Documents

Publication Publication Date Title
CY1106973T1 (el) Παραγωγα θειαζολινης ως εκλεκτικοι διαμορφωται υποδοχεως ανδρογονου (sarms)
MY142048A (en) Novel heterocycle derivatives useful as selective androgen receptor modulators (sarms)
TW200621725A (en) Novel benzimidazole derivatives useful as selective androgen receptor modulators (sarms)
SG10201809390QA (en) Modulators of indoleamine 2,3-dioxygenase and methods of using the same
TW200624424A (en) Novel benzimidazole derivatives useful as selective androgen receptor modulators (sarms)
DE60224928D1 (de) Dermatologische und kosmetische zusammensetzungen enthaltend ein furfurylderivat
DE60003863D1 (de) Dioxocyclopentylhydroxamsäure
BR0315547A (pt) Derivados de quinolina como antagonistas de crth2
CY1110115T1 (el) Παραγωγα ακετυλενυλο-πυραζολο-πυριμιδινης ως mglur2 ανταγωνιστες
ATE433447T1 (de) Pyrimiidinverbindungen
TW200606146A (en) Novel indole derivatives as selective androgen receptor modulators (SARMS)
MXPA05009304A (es) Derivados de indol utiles para el tratamiento de enfermedades.
NO20063821L (no) Kinolinderivater for anvendelse som mykobakterielle inhibitorer
AU2003276028A1 (en) Pyridine derivatives as cb2 receptor modulators
EA201001682A1 (ru) Производные фенил- и бензодиоксинилзамещенных индазолов
MA32811B1 (fr) Nouveaux composés
MXPA06000921A (es) Derivados de benzamidazoles como inhibidores de mek.
MX2007011698A (es) Derivados de oxindol sustituido, medicamentos que contienen dichos derivados y uso de los mismos.
TW200604171A (en) Novel indole derivatives as selective androgen receptor modulators (SARMs)
TW200604170A (en) Novel indole derivatives as selective androgen receptor modulators (SARMs)
MXPA06003363A (es) Derivados de fenil-piperazina como moduladores de receptores muscarinicos.
SE0300456D0 (sv) Novel compounds
CY1109371T1 (el) Παραγωγα σουλφαμικου βενζοθειοφαινιου ως αναστολεις σουλφατασης στεροειδους
ES2345882T3 (es) Nuevos compuestos y su uso como moduladores de ppar.
ATE419242T1 (de) Pyrrolidinylharnstoffderivate als angiogeneseinhibitoren